Unexpected HBsAg decrease after nucleoside analogues retreatment among HBeAg positive postpartum women: a pilot study
HBeAg positive patients received NAs treatment during pregnancy and discontinued it postpartum can benefit from NAs retreatment because of unexpected decrease of HBsAg, which may be helpful for achieve the goal of functional cure. Trial registration number ClinicalTrials.gov (No.ChiCTR2100054116).
Authors
- Qiao Tang
- Yunling Xue
- Peng Hu (ORCID: https://orcid.org/0000-0001-8481-0841)
- Xiaoqing Liu (ORCID: https://orcid.org/0000-0002-4034-5156)
- Li Zhang (ORCID: https://orcid.org/0000-0002-6118-4750)
- Hu Li (ORCID: https://orcid.org/0000-0002-7917-7807)
- Yue Qiu (ORCID: https://orcid.org/0000-0003-4714-9745)
- Mingli Peng (ORCID: https://orcid.org/0000-0002-9764-3445)
- Zhiwei Chen (ORCID: https://orcid.org/0009-0000-5960-5731)
- Yi Zeng
- Chunrui Wang (ORCID: https://orcid.org/0000-0003-0847-4166)
- Jing Zhang (ORCID: https://orcid.org/0000-0002-7650-4702)
Institutions
- Dalian Medical University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Virology Journal
- Published
- 2025-02-13
- DOI
- https://doi.org/10.1186/s12985-025-02632-x
- Citations
- 1
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- National Natural Science Foundation of China
- Chongqing Medical University
- Chongqing Municipal Education Commission
- National Science and Technology Major Project